HIF1A and Parkinson disease: In vitro models of AD and PD verified that stimulation by certain neuroprotective drugs, such as multifunctional brain-penetrating iron chelator M30 or deferoxamine (DFO), could increase the expression level of HIF-1α to promote the activation of antioxidant pathways and exert neuroprotective effects.